Note: Ingredients listed on restricted chemical lists
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
1-5
General Information
Version
2.02
Revision date
2025-02-21
Product name
RAL 5017 TRAFFIC BLUE HYBRID
1.2.1 Relevant identified uses
Industrial applications
supplier name
PPG Canada Inc
Emergency telephone
1-888-774-2001
Icons in SDS
Company Information
company name
PPG Canada Inc
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H351
Hazard statements
Code
Statements
H351
Suspected of causing cancer
Section 2
SECTION 2: Hazards identification
Classification of the substance or mixture
Product definition
Mixture Classification according to UK CLP/GHS Aquatic Chronic 3, H412
Signal word
No signal word.
Hazard statements
Harmful to aquatic life with long lasting effects.
Prevention
Avoid release to the environment.
Response
Not applicable.
Storage
Not applicable.
Disposal
Dispose of contents and container in accordance with all local, regional, national and international regulations. P273, P501
Supplemental label elements
Not applicable. elements
Annex XVII - Restrictions on the manufacture, placing on the market and use of certain dangerous substances, mixtures and articles
Not applicable.
Special packaging requirements
Containers to be fitted Not applicable. with child-resistant fastenings
Tactile warning of danger
Not applicable.
2.3 Other hazards
Product meets the criteria This mixture does not contain any substances that are assessed to be a PBT or a for PBT or vPvB according vPvB. to Regulation (EC) No.
Other hazards which do not result in classification
May form explosible dust-air mixture if dispersed. Handling and/or processing of this material may generate a dust which can cause mechanical irritation of the eyes, skin, nose and throat.
2.1 Classification of the substance or mixture
Product definition : Mixture Classification according to UK CLP/GHS Aquatic Chronic 3, H412 The product is classified as hazardous according to UK CLP Regulation SI 2019/720 as amended. See Section 16 for the full text of the H statements declared above. See Section 11 for more detailed information on health effects and symptoms.
